Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma

References

• Spencer CD, Weiss RB, Van Eys J, Cohen P, Edwards B. Medulloblastoma metastatic to the marrow. Report of four cases and review of the literature. J Neurooncol 1984;2: 223–35.
   PubMed Web of Science ®Google Scholar
• Mazloom A, Zangeneh AH, Paulino AC. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys 2010;78:72–8.
   PubMed Web of Science ®Google Scholar
• Al-Halabi H, Nantel A, Klekner A, Guiot MC, Albrecht S, Hauser P, et al. Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. Acta Neuropathol 2011;121:229–39.
   PubMed Web of Science ®Google Scholar
• Remke M, Hielscher T, Northcott PA, Witt H, Ryzhova M, Wittmann A, et al. Adult medulloblastoma comprises three major molecular variants. J Clin Oncol 2011;29:2717–23.
   PubMed Web of Science ®Google Scholar
• Dlugosz AA, Talpaz M. Following the hedgehog to new cancer therapies. N Engl J Med 2009;361:1202–5.
   PubMed Web of Science ®Google Scholar
• Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361: 1173–8.
   PubMed Web of Science ®Google Scholar
• Chalkidou A, Landau DB, Odell EW, Cornelius VR, O’Doherty MJ, Marsden PK. Correlation between Ki-67 immunohistochemistry and 18F-Fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. Eur J Cancer Epub2012 May 31.
   Google Scholar
• Price SJ, Fryer TD, Cleij MC, Dean AF, Joseph J, Salvador R, et al. Imaging regional variation of cellular proliferation in gliomas using 3’-deoxy-3’-[18F]fluorothymidine positron-emission tomography: An image-guided biopsy study. Clin Radiol 2009;64:52–63.
   PubMed Web of Science ®Google Scholar
• Backes H, Ullrich R, Neumaier B, Kracht L, Wienhard K, Jacobs AH. Noninvasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma. Eur J Nucl Med Mol Imaging 2009;36:1960–7.
   PubMed Web of Science ®Google Scholar
• Agool A, Slart RH, Thorp KK, Glaudemans AW, Cobben DC, Been LB, et al. Effect of radiotherapy and chemotherapy on bone marrow activity: A 18F-FLT-PET study. Nucl Med Commun 2011;32:17–22.
   PubMed Web of Science ®Google Scholar
• Vanderhoek M, Juckett MB, Perlman SB, Nickles RJ, Jeraj R. Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leuk Res 2011;35:310–6.
   PubMed Web of Science ®Google Scholar
• Cook GJ. PET and PET/CT imaging of skeletal metastases. Cancer Imaging 2010;10:1–8.
   PubMedGoogle Scholar
• Withofs N, Grayet B, Tancredi T, Rorive A, Mella C, Giacomelli F, et al. (1)(8)F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nucl Med Commun 2011;32:168–76.
   PubMed Web of Science ®Google Scholar
• Iagaru A, Mittra E, Dick DW, Gambhir SS. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases. Mol Imaging Biol 2012;14:252–9.
   PubMed Web of Science ®Google Scholar
• Kieran MW, Turner CD, Rubin JB, Chi SN, Zimmerman MA, Chordas C, et al. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol 2005;27: 573–81.
   PubMed Web of Science ®Google Scholar
• Buchroithner J, Nußbaumer K, Pichler S, Weis S. Anti- angiogenetic metronomic chemotherapy in an adult with recurrent medulloblastoma with spinal metastases: A case report. Mag Eur Med Oncol 2010;3(Suppl 3):25–7.
   Google Scholar
• Kim CH. Homeostatic and pathogenic extramedullary hematopoiesis. J Blood Med 2010;1:13–9.
   PubMedGoogle Scholar
• Di Marcotullio L, Ferretti E, De Smaele E, Argenti B, Mincione C, Zazzeroni F, et al. REN(KCTD11) is a suppressor of hedgehog signaling and is deleted in human medulloblastoma. Proc Natl Acad Sci U S A 2004;101:10833–8.
   PubMed Web of Science ®Google Scholar
• Bar EE, Chaudhry A, Farah MH, Eberhart CG. Hedgehog signaling promotes medulloblastoma survival via Bc/II. Am J Pathol 2007;170:347–55.
   PubMed Web of Science ®Google Scholar
• Lorusso PM, Jimeno A, Dy G, Adjei A, Berlin J, Leichman L, et al. Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors. Clin Cancer Res 2011;17:5774–82.
   PubMed Web of Science ®Google Scholar
• LoRusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, Borad MJ, et al. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res 2011; 17:2502–11.
   PubMed Web of Science ®Google Scholar
• Metcalfe C, de Sauvage FJ. Hedgehog fights back: Mechanisms of acquired resistance against smoothened antagonists. Cancer Res 2011;71:5057–61.
   PubMed Web of Science ®Google Scholar